NCT07100444Completed
Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival
Source: ClinicalTrials.gov · Last updated 3 Aug 2025
Brief summary (registry, in English)
The aim of this study is to compare the clinical features and postoperative survival outcomes between patients with spinal metastasis as the initial manifestation of malignancy and those with spinal metastasis occurring after an established diagnosis of malignancy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 139 (actual)
- First submitted
- 24 Jul 2025
- Start date
- Jan 2018
- Primary completion date
- Mar 2025
- Lead sponsor
- Guangdong Provincial People's Hospital
- Diseases
- Lung cancer
- NCT number
- NCT07100444
What you commit to
- Study type: Observational
- Participants enrolled: 139
- From Jan 2018 to the primary completion date, Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who did not receive surgical treatment for spinal metastasis.
Other
- Patients with spinal metastasis originating from non-lung primary tumors.
- Incomplete clinical data or lost to follow-up.
Who the study is looking for
- Age ≥ 18 years.
- Pathologically or radiologically confirmed diagnosis of lung cancer with spinal metastasis.
- Patients with spinal metastasis who underwent surgical intervention.
- Adequate medical records and follow-up data available.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangdong Provincial People's Hospital Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.